NLRP3 and Alzheimer disease: In this study, a sporadic Alzheimer’s disease (SAD) mouse model induced by streptozotocin (STZ) injection was utilized and demonstrated that NLRP3-mediated microglial training exacerbates microglial pro-inflammatory responses, while impairing Aβ phagocytosis.